The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 775.00
Bid: 0.00
Ask: 3,550.00
Change: 0.00 (0.00%)
Spread: 2,764.00 (351.654%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 775.00
FUTR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - FUTURE PLC AMENDMENT

3 Feb 2021 16:08

 

FORM 8.3 Amendment to Sales

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:Barclays PLC.
 
(b)Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whoseFUTURE PLC
relevant securities this form relates:
(d)If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:28 January 2021
(f)In addition to the company in 1(c) above, is the discloser makingYES:
disclosures in respect of any other party to the offer?GOCO GROUP PLC
 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:15p ordinary
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned

 

 

 

 

and/or controlled:

502,813

0.51%

645,922

0.66%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

484,143

0.49%

114,168

0.12%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

986,956

1.01%

760,090

0.78%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/saleNumber ofPrice per unit
securitysecurities

15p ordinary

Purchase

8

17.5800 GBP

15p ordinary

Purchase

10

17.6800 GBP

15p ordinary

Purchase

26

16.8800 GBP

15p ordinary

Purchase

81

17.4130 GBP

15p ordinary

Purchase

127

17.3548 GBP

15p ordinary

Purchase

145

17.3000 GBP

15p ordinary

Purchase

402

17.3497 GBP

15p ordinary

Purchase

519

17.1428 GBP

15p ordinary

Purchase

1,072

17.6191 GBP

15p ordinary

Purchase

1,460

17.1911 GBP

15p ordinary

Purchase

1,500

17.1200 GBP

15p ordinary

Purchase

1,729

17.6200 GBP

15p ordinary

Purchase

2,093

17.4208 GBP

15p ordinary

Purchase

4,263

17.2243 GBP

15p ordinary

Sale

15

17.2800 GBP

15p ordinary

Sale

25

17.6400 GBP

15p ordinary

Sale

33

17.5400 GBP

15p ordinary

Sale

54

17.6600 GBP

15p ordinary

Sale

84

17.2282 GBP

15p ordinary

Sale

129

17.1685 GBP

15p ordinary

Sale

145

17.3000 GBP

15p ordinary

Sale

160

17.4578 GBP

15p ordinary

Sale

242

17.0754 GBP

15p ordinary

Sale

306

17.2600 GBP

15p ordinary

Sale

908

17.0494 GBP

15p ordinary

Sale

964

17.3526 GBP

15p ordinary

Sale

1,714

17.6217 GBP

15p ordinary

Sale

1,827

17.1239 GBP

15p ordinary

Sale

2,487

17.6200 GBP

15p ordinary

Sale

3,952

17.4211 GBP

15p ordinary

Sale

22,828

17.3688 GBP

(b) Cash-settled derivative transactions

Class ofProductNature of dealingNumber ofPrice per
relevantdescriptionreferenceunit
securitysecurities

15p ordinary

SWAP

Long

50

17.6200 GBP

15p ordinary

CFD

Long

58

16.8977 GBP

15p ordinary

CFD

Long

843

17.6185 GBP

15p ordinary

SWAP

Long

964

17.3526 GBP

15p ordinary

SWAP

Long

1,215

17.1848 GBP

15p ordinary

SWAP

Long

4,242

17.6270 GBP

15p ordinary

CFD

Long

6,957

17.1451 GBP

15p ordinary

SWAP

Long

12,558

17.3465 GBP

15p ordinary

CFD

Short

33

17.6312 GBP

15p ordinary

CFD

Short

55

16.8709 GBP

15p ordinary

CFD

Short

75

16.8606 GBP

15p ordinary

SWAP

Short

409

17.0548 GBP

15p ordinary

CFD

Short

519

17.1428 GBP

15p ordinary

SWAP

Short

731

17.1663 GBP

15p ordinary

CFD

Short

1,366

17.5623 GBP

15p ordinary

SWAP

Short

2,263

17.1242 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:3 Feb 2021
Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210203005703/en/

Copyright Business Wire 2021

Date   Source Headline
22nd May 202310:32 amRNSHolding(s) in Company
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNS2023 Interim Year Results
2nd May 20233:16 pmRNSTotal Voting Rights
4th Apr 202310:06 amRNSCEO Appointment
3rd Apr 20235:12 pmRNSTotal Voting Rights and Share Capital
30th Mar 20233:20 pmRNSDirector Declaration
30th Mar 20237:00 amRNSCompany Secretary Change
13th Mar 20237:00 amRNSNo material exposure to Silicon Valley Bank
1st Mar 202310:04 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSHolding(s) in Company
22nd Feb 20237:00 amRNSAppointment of Jon Steinberg as CEO
14th Feb 20234:35 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20231:51 pmRNSResult of AGM
8th Feb 20237:00 amRNSAGM trading statement
7th Feb 20232:39 pmRNSHolding(s) in Company
3rd Feb 202311:10 amRNSHolding(s) in Company
31st Jan 20231:40 pmRNSTotal Voting Rights
11th Jan 20231:41 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSEBT share purchase
3rd Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 20232:27 pmRNSBlock listing Interim Review
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 20227:00 amRNSDirector/PDMR Shareholding
15th Dec 202210:51 amRNSAnnual Financial Report
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20229:57 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSFull Year Results
3rd Nov 202212:23 pmRNSDirector Declaration
31st Oct 20229:32 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20222:16 pmRNSHolding(s) in Company
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
20th Sep 202210:35 amRNSResponse to press speculation
15th Sep 20227:14 amRNSDirector Declaration
14th Sep 20227:00 amRNSCapital Market Event
13th Sep 20227:00 amRNSTrading Update
12th Sep 20227:00 amRNSDirector/PDMR Shareholding
31st Aug 20229:35 amRNSTotal Voting Rights
8th Aug 20228:32 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSNotice of Capital Markets Event
29th Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20228:27 amRNSTotal Voting Rights
30th Jun 20228:25 amRNSBlock listing Interim Review
17th Jun 20227:00 amRNSCompletion of Acquisition & Trading update
15th Jun 20221:19 pmRNSEBT share purchase
31st May 20228:24 amRNSTotal Voting Rights
25th May 20223:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.